Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ASCHAN, Johan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

Allogeneic haematopoietic stem cell transplantation : current status and future outlookASCHAN, Johan.British medical bulletin. 2006, Vol 77-78, pp 23-36, issn 0007-1420, 14 p.Article

Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell TransplantationAVETISYAN, Gayane; ASCHAN, Johan; HASSAN, Moustapha et al.Transplantation. 2008, Vol 86, Num 2, pp 257-263, issn 0041-1337, 7 p.Article

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulinREMBERGER, Mats; ASCHAN, Johan; BARKHOLT, Lisbeth et al.Clinical transplantation. 2001, Vol 15, Num 3, pp 147-153, issn 0902-0063Article

Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasisWAHLIN, Staffan; ASCHAN, Johan; BJÖRNSTEDT, Mikael et al.Journal of hepatology. 2007, Vol 46, Num 1, pp 174-179, issn 0168-8278, 6 p.Article

Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirusLARSSON, Kajsa; ASCHAN, Johan; REMBERGER, Mats et al.Transplantation. 2004, Vol 77, Num 4, pp 526-531, issn 0041-1337, 6 p.Article

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantationUZUNEL, Mehmet; MATTSSON, Jonas; BRUNE, Mats et al.Blood. 2003, Vol 101, Num 2, pp 469-472, issn 0006-4971, 4 p.Article

Allogeneic hematopoietic stem cell transplantation for inherited disorders : Experience in a single centerRINGDEN, Olle; REMBERGER, Mats; SVENBERG, Petter et al.Transplantation. 2006, Vol 81, Num 5, pp 718-725, issn 0041-1337, 8 p.Article

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donorsREMBERGER, Mats; RINGDEN, Oolle; FAUSER, Axel A et al.Blood. 2001, Vol 98, Num 6, pp 1739-1745, issn 0006-4971Article

Clinical tolerance after allogeneic hematopoietic stem cell transplantation: A study of influencing factorsHENTSCHKE, Patrik; REMBERGER, Mats; MATTSSON, Jonas et al.Transplantation. 2002, Vol 73, Num 6, pp 930-936, issn 0041-1337Article

Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donorsLJUNGMAN, Per; LARSSON, Kajsa; KUMLIEN, Gunilla et al.Scandinavian journal of infectious diseases. 2002, Vol 34, Num 5, pp 347-350, issn 0036-5548Article

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantationMATTSSON, Jonas; UZUNEL, Mehmet; BRUNE, Mats et al.British journal of haematology. 2001, Vol 115, Num 4, pp 935-944, issn 0007-1048Article

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal populationLIWING, Johan; UTTERVALL, Katarina; KVIELE, Helene Haglöf et al.British journal of haematology. 2014, Vol 164, Num 5, pp 684-693, issn 0007-1048, 10 p.Article

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. CommentaryBOLANOS-MEADE, Javier; VOGELSANG, Georgia B; SZAKOS, Attila et al.Transplantation. 2006, Vol 81, Num 10, issn 0041-1337, 1388-1389,1390-1397 [10 p.]Article

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital careSVAHN, Britt-Marie; REMBERGER, Mats; MYRBÄCK, Karl-Erik et al.Blood. 2002, Vol 100, Num 13, pp 4317-4324, issn 0006-4971, 8 p.Article

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine ConditioningCASPER, Jochen; WOLFF, Daniel; ASCHAN, Johan et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3344-3351, issn 0732-183X, 8 p.Article

Hemorrhagic cystitis : a retrospective single-center surveyHASSAN, Zuzana; REMBERGER, Mats; ASCHAN, Johan et al.Clinical transplantation. 2007, Vol 21, Num 5, pp 659-667, issn 0902-0063, 9 p.Article

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantationLJUNGMAN, Per; PEREZ-BERCOFF, Lena; RINGDEN, Olle et al.Haematologica (Roma). 2006, Vol 91, Num 1, pp 78-83, issn 0390-6078, 6 p.Article

An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantationREMBERGER, Mats; ASCHAN, Johan; LÖNNQVIST, Berit et al.European journal of haematology. 2001, Vol 66, Num 1, pp 50-56, issn 0902-4441Article

  • Page / 1